Case File
efta-01805086DOJ Data Set 10OtherEFTA01805086
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-01805086
Pages
2
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From:
Eileen Alexanderson
Sent:
Thursday, April 4, 2013 2:32 PM
To:
'Jeffrey Epstein'
Subject:
FW: Apollo
Jeffrey-See note below from Patrick Fe=n to Tom. We are planning to meet at Akin tomorrow at 2-do you want to join
either in person or via teleconference?
From: Thomas T=rrin [mail
Sent: Thursday, April 04, 20=3 10:18 AM
To: Fenn, Patrick; Ada Clapp= Eileen Alexanderson
Subject: Re: Apollo</=ont>
Pat,
I'm available tomorrow afternoon to meet at your office. I am including Ada and Eileen in my reply. Let me know what
time works.=/o:p>
Best,
Sent from my Ver=zon Wireless 4G LTE DROID
"Fenn, Patrick"
Hi Tom.
ote:
I have been asked to work with Leon, Josh and Marc's tax advisors to evalua=e whether certain deferral techniques
might be appropriate for the individual= in light of the need to refinance indebtedness of AMH and the potential to
exchange exisiting Apollo Group interests for AGM units. I beli=ve you might be familiar with some of what I am
referring to. Is there a time late afternoon today or afternoon tomorrow that we could meet or have = call to discuss
Leon=/stl:place>'s situation and give you background on the work I we have been doing around t=ese issues? Should
Eileen or Ada be involved with this as well?
Look forward to speaking with you.
Regards
IRS Circular 230 Notice Requirement: This communication is not given in the form of a covered opinion, within the
meaning of Circular 230 issued by the United States Secretary of the Treasury. Thus, we are required to inform yo= that
EFTA_R1_00151137
EFTA01805086
you cannot rely upon any tax advice contained in this communication fo= the purpose of avoiding United States federal
tax penalties. In additio=, any tax advice contained in this communication may not be used to promote, market or
recommend a transaction to another party.
The information contained in this e-mail message is intended only for the personal and confidential use of the
recipient(s) named above. If you have received this communication in error, please notify us immediately by e-mai., and
delete the original message.
=nbsp;
&nb=p;
CONFIDENTIALITY STATEMENT<=b>: The information contained in this electronic communicat=on, including any and all
attachments and enclosures, may be privileged and is strictly confidential, intended solely for the use of the person(s)
identif=ed above to receive this communication. If you are not the person(s) identifie= above to receive this
communication, you are hereby notified that you may n=t disclose print, copy, disseminate, or otherwise use the
information contain=d herein. If you are an employee or agent of the person(s) identified above t= receive this
communication and, as such, you have been authorized to delive= this communication to such person(s), you may
disclose, print, copy, disseminate, or otherwise use the information contained in this communicati=n solely for the
purpose of such delivery. Unauthorized interception and/or u=e of this communication are/is strictly prohibited and may
be punishable by l=w. If you have received this communication in error, please reply and notify t=e sender (only) of that
fact and delete the communication, including any and =11 attachments and enclosures, from your computer or other
electronic device o= which you may have received this communication.
CIRCULAR 230 DISCLOSURE:</=> To insure compliance with requirements imposed by the Internal Revenue Service= we
inform you that any tax advice contained in this communication (including a=y and all attachments), unless expressly
stated otherwise, was not intended or written to be used and cannot be used for the purpose of (i) avoiding tax-related
penalties imposed by the Internal Revenue Code or (ii) promotin=, marketing, or recommending to another party any
transaction(s) or tax-relat=d matter(s) addressed herein. This communication may not be forwarded (other =han to the
addressee(s) identified above) without our express written consent.<=:p>
This email and any files transmitted with it are confidential and intended solely for the person or entity to whom they
are addressed and may contain confidential and/or privileged =material. Any review, retransmission, dissemination or
=other use of, or taking of any action in reliance upon this information by persons or entities other than the intended
=recipient is prohibited. If you have received this email in =error please contact the sender and delete the material from
=any computer.
Apollo Global Management, LLC
=0
2
EFTA_R1_00151138
EFTA01805087
Technical Artifacts (2)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Wire Ref
referringWire Ref
refinanceRelated Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.